GSH‐Depleted Platinum(II) Metallacycles to Turn On the NIR Emission in Boosting Synergistic Cancer Therapy
Open Access
Abstract
Agents to combine functions simultaneously are highly needed but still challenging in synergistic therapy. Particularly, capabilities to deplete glutathione (GSH) in tumors and monitor their process are also important. Therefore, platinum(II) metallacycles are prepared by using aggregation‐induced emission active ligands. Despite their similar structures, high emission for Mh1 is obtained (PLQY = 49.2%) in solids, but a PLQY of only 6.8% is recorded for Mh2. NIR emission in Mh2 can be turned‐on in depleting GSH by releasing emissive ligands. Also, both type I and type II reactive oxygen species (ROS) are obtained in Mh2 nanoparticles. Due to the depletion of GSH and generation of ROS, oxidative stress in immunogenic cell death can be induced. By combining chemotherapy and photoimmunotherapy, synergistic therapy in vivo is obtained for Mh2‐NPs to well inhibit the tumor growth, also showing antitumor immune effects in distant tumors. The work here provides some guidelines in designing the multi‐functional agents, showing the great potentials in efficient cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (U24A20523)
- National Natural Science Foundation of China (22475166)
- National Natural Science Foundation of China (52203239)
- National Natural Science Foundation of China (22271198)
This publication has 52 references indexed in Scilit:
- A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated TumorsAngewandte Chemie International Edition, 2024
- A Polyplatin with Hands‐Holding Near‐Infrared‐II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment FeedbackAdvanced Materials, 2024
- Less is More: Asymmetric D–A Type Agent to Achieve Dynamic Self‐Assembled Nanoaggregates for Long‐Acting Photodynamic TherapyAdvanced Materials, 2024
- Photo‐Induced Disproportionation‐Mediated Photodynamic Therapy: Simultaneous Oxidation of Tetrahydrobiopterin and Generation of Superoxide RadicalsAngewandte Chemie International Edition, 2024
- Glutathione‐Depleting Organic Metal Adjuvants for Effective NIR‐II Photothermal ImmunotherapyAdvanced Materials, 2022
- Glutathione Depletion‐Induced Activation of Dimersomes for Potentiating the Ferroptosis and Immunotherapy of “Cold” TumorAngewandte Chemie International Edition, 2022
- Triple‐Jump Photodynamic Theranostics: MnO2 Combined Upconversion Nanoplatforms Involving a Type‐I Photosensitizer with Aggregation‐Induced Emission Characteristics for Potent Cancer TreatmentAdvanced Materials, 2021
- Metallacycles, metallacages, and their aggregate/optical behaviorAggregate, 2021
- Gathering brings strength: How organic aggregates boost disease phototheranosticsAggregate, 2021
- Emissive Metallacycle‐Crosslinked Supramolecular Networks with Tunable Crosslinking Densities for Bacterial Imaging and KillingAngewandte Chemie International Edition, 2020